Henry Schein Inc HSIC

$88.41 +2.36 (2.74%)

Valuation

Market cap
9,511,881,000
Revenue TTM
$13,184,000,000
Net income TTM
$398,000,000
P/E (trailing)
15.54
P/E (forward)
15.38
Profit margin
3.02%
Debt to equity
0.64

Trading

Volume
1,761,915
Avg volume
1,328,268
Day's range
$86.26 – $88.89
Shares out
110,539,000
Stochastic %K
58%
Beta
0.87
Analysts
Moderate Buy
Price target
$96.38

Price

Company profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, te...

Show more

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Industry
Medical Distribution
Sector
Healthcare
Phone
631 843 5500
Website
https://www.henryschein.com
Address
135 Duryea Road, Melville, United States

Latest news

Stocktwits

topstockalerts Nov 3, 9:11 PM
Henry Schein reported mixed Q3 2026 results, beating earnings expectations but slightly missing revenue estimates, triggering a sharp selloff. Adjusted EPS came in at $1.56, well above the $1.36 consensus, while revenue reached $3.47 billion, narrowly below the $3.48 billion estimate. Investors questioned the quality of the earnings beat, as part of the improvement came from one-time tariff-reimbursement benefits rather than organic margin expansion. Organic revenue growth was 3.1% in local currencies, although U.S. dental merchandise sales rose 8.6%, driven mainly by higher volumes and market-share gains. CEO Fred Lowery also said the company would make deliberate incremental investments in Q4 to attract new customers and turn occasional buyers into long-term clients, raising concerns about near-term margin pressure. $HSIC
0 replies
STUnusualVolume Nov 3, 8:45 PM
$HSIC is trading at 3.5x its normal volume for this time of day.
0 replies
Following_the_trend Nov 3, 8:24 PM
$HSIC Grabbed a few shares on the open. Otherwise, sitting on my hands today.
0 replies
EarningsInsider Nov 3, 2:16 PM
https://www.marketbeat.com/earnings/reports/2026-11-3-henry-schein-inc-stock/ $HSIC Henry Schein Earnings Transcript
0 replies
StocktwitsEarnings Nov 3, 12:45 PM
$HSIC Q3 '26 Earnings Results & Recap Henry Schein raised FY2026 non-GAAP diluted EPS guidance to $5.50 to $5.56 and Adjusted EBITDA growth to high-single-digits; total sales growth guidance remains 4.5% to 5.5%.
0 replies
Trader_Ty Sep 3, 8:05 PM
$HSIC Flaggy over the weekly EMAs 👀
0 replies
Trader_Ty Aug 27, 12:09 PM
$HSIC respecting the moving averages correctly
1 replies
webroker Aug 20, 5:01 AM
$HSIC Still looking strong...
0 replies